Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Ticarcillin/Clavulanate in Pediatric Infections
NCT00092170Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2002
- Primary completion
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ertapenem in intra-abdominal infections (IAI), pelvic inflammatory disease (PID), sponsored by Merck & Co.. Started Mar 2002; status: completed.
02
Drugs
ertapenem
03
Conditions
intra-abdominal infections (IAI)pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT00092170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092170.